After matching treated and untreated groups using a propensity score analysis, the study found that treatment with statins and angiotensin-converting enzyme inhibitors/angiotensin receptor blockers was associated with a lower risk of major adverse cardiac events, while beta-blocker treatment showed a trend toward a positive effect [ 25 ].
← all excerpts
Prognostic Implications of Coronary Artery Sclerosis in Troponin-Positive Patients with Non-Obstructive Coronary Arteries.
1
—
—